Plasma concentrations of TNF-α and its soluble receptors sTNFR1 and sTNFR2 in patients with coronary artery disease

Tissue Antigens

Volumn 74, Issue 5, 2009, Pages 386-392

  Safranow, K ^a   Dziedziejko, V ^a   Rzeuski, R ^a   Czyycka, E ^a   Wojtarowicz, A ^a   Binczak Kuleta A ^a   Jakubowska, K ^a   Olszewska, M ^a   Ciechanowicz, A ^a   Kornacewicz Jach, Z ^a   MacHalinski B ^a   Pawlik, A ^a   Chlubek, D ^a  

^a POMERANIAN MEDICAL UNIVERSITY   (Poland)

Author keywords

Adenosine deaminase; AMP deaminase; Coronary artery disease; Genetic polymorphism; Heart failure; Renal function; STNFR1; STNFR2; TNF

Indexed keywords

ADENOSINE; ADENOSINE DEAMINASE; ADENOSINE MONOPHOSPHATE DEAMINASE; HEMOGLOBIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR 1; TUMOR NECROSIS FACTOR RECEPTOR 2; URIC ACID;

ADULT; ARTICLE; ASTHMA; BLOOD LEVEL; CHOLESTEROL BLOOD LEVEL; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONCENTRATION (PARAMETERS); CORONARY ARTERY DISEASE; DIABETES MELLITUS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENETIC ASSOCIATION; GENETIC CODE; GENETIC POLYMORPHISM; GENOTYPE; GLOMERULUS FILTRATION RATE; HEART FAILURE; HEART FUNCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEMOGLOBIN BLOOD LEVEL; HUMAN; KIDNEY FUNCTION; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; URIC ACID BLOOD LEVEL;

AGED; CORONARY ARTERY DISEASE; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OSMOLAR CONCENTRATION; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE II; SEVERITY OF ILLNESS INDEX; SOLUBILITY; TUMOR NECROSIS FACTOR-ALPHA;

EID: 70350074632     PISSN: 00012815     EISSN: 13990039     Source Type: Journal    
DOI: 10.1111/j.1399-0039.2009.01332.x     Document Type: Article

References (38)

1. Meldrum DR, Cleveland JC Jr., Cain BS, Meng X, Harken AH. Increased myocardial tumor necrosis factor-alpha in a crystalloid-perfused model of cardiac ischemia-reperfusion injury. Ann Thorac Surg 1998 : 65 : 439 443.
2. Baker SJ, Reddy EP. Transducers of life and death: TNF receptor superfamily and associated proteins. Oncogene 1996 : 12 : 1 9.
3. Baxter GT, Kuo RC, Jupp OJ, Vandenabeele P, MacEwan DJ. Tumor necrosis factor-alpha mediates both apoptotic cell death and cell proliferation in a human hematopoietic cell line dependent on mitotic activity and receptor subtype expression. J Biol Chem 1999 : 274 : 9539 9547.
4. Pober JS, Cotran RS. Cytokines and endothelial cell biology. Physiol Rev 1990 : 70 : 427 451.
5. 2+ transients. FEBS Lett 1995 : 376 : 24 30.
6. Torre-Amione G, Kapadia S, Lee J, Bies RD, Lebovitz R, Mann DL. Expression and functional significance of tumor necrosis factor receptors in human myocardium. Circulation 1995 : 92 : 1487 1493.
7. Giroir BP, Johnson JH, Brown T, Allen GL, Beutler B. The tissue distribution of tumor necrosis factor biosynthesis during endotoxemia. J Clin Invest 1992 : 90 : 693 698.
8. Kapadia S, Lee J, Torre-Amione G, Birdsall HH, Ma TS, Mann DL. Tumor necrosis factor-alpha gene and protein expression in adult feline myocardium after endotoxin administration. J Clin Invest 1995 : 96 : 1042 1052.
9. Gurevitch J, Frolkis I, Yuhas Y et al. Tumor necrosis factor-alpha is released from the isolated heart undergoing ischemia and reperfusion. J Am Coll Cardiol 1996 : 28 : 247 252.
10. Irwin MW, Mak S, Mann DL et al. Tissue expression and immunolocalization of tumor necrosis factor-alpha in postinfarction dysfunctional myocardium. Circulation 1999 : 99 : 1492 1498.
11. Yue P, Massie BM, Simpson PC, Long CS. Cytokine expression increases in nonmyocytes from rats with postinfarction heart failure. Am J Physiol 1998 : 275 : H250 8.
12. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001 : 285 : 2486 2497.
13. International Diabetes Federation: The IDF consensus worldwide definition of the metabolic syndrome. http://www.idf.org/webdata/docs/IDF-Meta-def-final. pdf.
14. Safranow K, Rzeuski R, Binczak-Kuleta A et al. ADA*2 allele of the adenosine deaminase gene may protect against coronary artery disease. Cardiology 2007 : 108 : 275 281.
15. Safranow K, Czyzycka E, Binczak-Kuleta A et al. Association of C34T AMPD1 gene polymorphism with features of metabolic syndrome in patients with coronary artery disease or heart failure. Scand J Clin Lab Invest 2009 : 69 : 102 112.
16. Levine B, Kalman J, Mayer L, Fillit HM, Packer M. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N Engl J Med 1990 : 323 : 236 241.
17. Testa M, Yeh M, Lee P et al. Circulating levels of cytokines and their endogenous modulators in patients with mild to severe congestive heart failure due to coronary artery disease or hypertension. J Am Coll Cardiol 1996 : 28 : 964 971.
18. Ridker PM, Rifai N, Pfeffer M, Sacks F, Lepage S, Braunwald E. Elevation of tumor necrosis factor-alpha and increased risk of recurrent coronary events after myocardial infarction. Circulation 2000 : 101 : 2149 2153.
19. Meldrum DR, Meng X, Dinarello CA et al. Human myocardial tissue TNFalpha expression following acute global ischemia in vivo. J Mol Cell Cardiol 1998 : 30 : 1683 1689.
20. Maekawa N, Wada H, Kanda T et al. Improved myocardial ischemia/reperfusion injury in mice lacking tumor necrosis factor-alpha. J Am Coll Cardiol 2002 : 39 : 1229 1235.
21. Pecoits-Filho R, Heimbürger O, Bárány P et al. Associations between circulating inflammatory markers and residual renal function in CRF patients. Am J Kidney Dis 2003 : 41 : 1212 1218.
22. Hillege H, Van Gilst W, de Zeeuw D, van Veldhuisen DJ. Renal function as a predictor of prognosis in chronic heart failure. Heart Fail Monit 2002 : 2 : 78 84.
23. Schiele F. Renal dysfunction and coronary disease: a high-risk combination. J Nephrol 2009 : 22 : 39 45.
24. Deswal A, Petersen NJ, Feldman AM, Young JB, White BG, Mann DL. Cytokines and cytokine receptors in advanced heart failure: an analysis of the cytokine database from the Vesnarinone trial (VEST). Circulation 2001 : 103 : 2055 2059. (Pubitemid 32373007)
25. Valgimigli M, Ceconi C, Malagutti P et al. Tumor necrosis factor-alpha receptor 1 is a major predictor of mortality and new-onset heart failure in patients with acute myocardial infarction: the Cytokine-Activation and Long-Term Prognosis in Myocardial Infarction (C-ALPHA) study. Circulation 2005 : 111 : 863 870.
26. Morange PE, Tregouet DA, Godefroy T et al. Polymorphisms of the tumor necrosis factor-alpha (TNF) and the TNF-alpha converting enzyme (TACE/ADAM17) genes in relation to cardiovascular mortality: the AtheroGene study. J Mol Med 2008 : 86 : 1153 1161.
27. Karadag F, Karul AB, Cildag O, Yilmaz M, Ozcan H. Biomarkers of systemic inflammation in stable and exacerbation phases of COPD. Lung 2008 : 186 : 403 409.
28. Sui X, Church TS, Meriwether RA, Lobelo F, Blair SN. Uric acid and the development of metabolic syndrome in women and men. Metabolism 2008 : 57 : 845 852.
29. Conraads VM, Bosmans JM, Schuerwegh AJ et al. Association of lipoproteins with cytokines and cytokine receptors in heart failure patients. Differences between ischaemic versus idiopathic cardiomyopathy. Eur Heart J 2003 : 24 : 2221 2226.
30. Sutherland JP, McKinley B, Eckel RH. The metabolic syndrome and inflammation. Metab Syndr Relat Disord 2004 : 2 : 82 104.
31. You T, Nicklas BJ, Ding J et al. The metabolic syndrome is associated with circulating adipokines in older adults across a wide range of adiposity. J Gerontol A Biol Sci Med Sci 2008 : 63 : 414 419.
32. Kowalska I, Straczkowski M, Nikolajuk A et al. Insulin resistance, serum adiponectin, and proinflammatory markers in young subjects with the metabolic syndrome. Metabolism 2008 : 57 : 1539 1544.
33. Straczkowski M, Kowalska I, Nikolajuk A et al. Plasma levels of soluble tumor necrosis factor-alpha receptors are related to total and LDL-cholesterol in lean, but not in obese subjects. Cardiovasc Diabetol 2006 : 5 : 14.
34. Marso SP, Murphy JW, House JA, Safley DM, Harris WS. Metabolic syndrome-mediated inflammation following elective percutaneous coronary intervention. Diab Vasc Dis Res 2005 : 2 : 31 6.
35. Cain BS, Meldrum DR, Dinarello CA, Meng X, Banerjee A, Harken AH. Adenosine reduces cardiac TNF-alpha production and human myocardial injury following ischemia-reperfusion. J Surg Res 1998 : 76 : 117 123.
36. Wagner DR, Kubota T, Sanders VJ, McTiernan CF, Feldman AM. Differential regulation of cardiac expression of IL-6 and TNF-alpha by A2- and A3-adenosine receptors. Am J Physiol 1999 : 276 : H2141 7.
37. Feldman AM, Wagner DR, McNamara DM. AMPD1 gene mutation in congestive heart failure: new insights into the pathobiology of disease progression. Circulation 1999 : 99 : 1397 1399.
38. Gastmann A, Sigusch HH, Henke A et al. Role of adenosine monophosphate deaminase-1 gene polymorphism in patients with congestive heart failure (influence on tumor necrosis factor-alpha level and outcome). Am J Cardiol 2004 : 93 : 1260 1264.